Prognostic Value Estimation of BRIP1 in Breast Cancer by Exploiting Transcriptomics Data Through Bioinformatics...

Area of Science:

• Oncology
• Genetics
• Bioinformatics

Background:

• Breast Cancer 1 Interacting Helicase 1 (BRIP1) is a tumor suppressor gene crucial for DNA repair and genetic stability.
• Mutations or overexpression of BRIP1 are linked to breast cancer (BC) development and progression.
• Understanding the prognostic value of BRIP1 is essential for improving breast cancer patient outcomes.

Purpose of the Study:

• To evaluate and validate the prognostic significance of the BRIP1 gene in breast cancer using bioinformatics approaches.
• To analyze BRIP1 mRNA expression in relation to clinical features, tumor subtypes, methylation status, and patient survival.
• To identify BRIP1 as a potential molecular biomarker for breast cancer prognosis.

Main Methods:

• Utilized transcriptomic (mRNA expression) data from multiple breast cancer databases.
• Compared BRIP1 expression levels between tumor and normal tissues, analyzing correlations with clinical parameters.
• Performed mutation analysis and assessed promoter methylation status of the BRIP1 gene.

Main Results:

• BRIP1 was significantly overexpressed in various breast cancer molecular subtypes and clinical statuses compared to normal tissues.
• Higher BRIP1 expression correlated with poor disease-specific, metastasis-free, relapse-free, and overall survival rates.
• BRIP1 alterations included somatic and germline mutations, with 42 identified mutations in BC patients.

Conclusions:

• BRIP1 overexpression is associated with adverse clinical features and poorer survival outcomes in breast cancer patients.
• BRIP1's role in DNA repair and its altered expression in cancer suggest its significance in tumorigenesis.
• BRIP1 warrants consideration as a valuable molecular biomarker for breast cancer prognosis.